Filing Details
- Accession Number:
- 0001104659-24-060261
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-13 08:47:51
- Reporting Period:
- 2024-05-10
- Accepted Time:
- 2024-05-13 08:47:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1875558 | Nuvectis Pharma Inc. | NVCT | Pharmaceutical Preparations (2834) | 862405608 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1896056 | Shay Shemesh | C/O Nuvectis Pharma, Inc. 1 Bridge Plaza, Suite 275 Fort Lee NJ 07024 | Chief Dev. & Ops. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-10 | 1,113 | $6.32 | 1,493,068 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects the weighted average purchase price. The range of prices for the shares purchased was $6.19 to $6.42. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price
- Includes 353,399 shares of restricted stock.
Billionaire Hedge Funds
